FDA grants quick review for 3 psychedelic drug trials

The FDA is granting a quick review of three experimental drug trials looking into the effects of using psychedelics to treat major depression and PTSD. >> The FDA commissioner said the drugs have the potential to address the nation's mental health crisis. Today's move comes nearly a week after President Trump signed an executive order to fasttrack research into psychedelics.NBC News medical reporter Erica Edwards joins us now. So Erica, we just had the commissioner on our show talking about this. tell us ab ...